Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication

Stopped Enrollment paused for greater than 6 months, data would not be relevant as enrollment took longer than expected.

Conditions

• Multiple Sclerosis

Interventions

• OTHER: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus

Sponsor

Providence Health & Services